Hepatitis C Virus Nonstructural Protein 5A Inhibits Thapsigargin-Induced Apoptosis

Xia Jiang(Xuzhou Medical College), Osamu Yokosuka(Chiba University)

PLoS ONE

November 19, 2014

10.1371/journal.pone.0113499

Cited by 24

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

|Gut|2019|720

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

|Hepatology International|2020|295

Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma

|International Journal of Cancer|2014|117

New antiviral therapies for chronic hepatitis C

|Hepatology International|2010|105

Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners

|PLoS ONE|2014|79